Top Stories
Kosmos will be embedded across discovery and development activities as Incyte looks to use experimental, clinical and biomarker data more directly in research decisions.
The partners will roll out educational initiatives across nine markets in Asia to raise awareness of digital pathology tools.
Atropos' predictive algorithms form the foundation of the clinical decision support solution, designed to identified underdiagnosed or undertreated patients.
The PD-L1 inhibitor is cleared for use in patients with muscle-invasive bladder cancer who have molecular residual disease following surgery.
The ECG2Stroke model was trained and validated on data from more than 200,000 patients.
Conference News
(New York, NY – May 19, 2026) – Pulmonologists and experts in respiratory medicine from the Mount Sinai Health System will present new research at the American Thoracic Society (ATS) 2026 Internation...
PHILADELPHIA, May 19, 2026 /PRNewswire/ -- Signant Health, a leading provider of evidence generation solutions for clinical trials, today announced that its scientific and medical teams will be on sit...
MONTRÉAL, May 19, 2026 /CNW/ - Gray, developer of the GrayOS care orchestration platform, announced last week during ESTRO the deployment of its solution at Gustave Roussy, the leading cancer center i...
May 18, 2026 | 4 minute readGreater differentiation of clinical details through contrast-rich images with reduced background noiseFor coronary procedures, a new ultra-low dose protocol employs over 50...
ST. PETERSBURG, Fla.--(BUSINESS WIRE)-- As healthcare providers and health plans grapple with growing continuous glucose monitoring (CGM) adoption and persistent gaps in diabetes outcomes alongside gr...
